Lamivir HBV Lamivudine Tablets About
We are responsibly fulfilling the high and urgent demands for Lamivir HBV Lamivudine Tablets in the markets. These tablets are given to the virus infected patients to prevent their bodies from the multiplication of human cells. The patients with HIV infection and chronic hepatitis B virus infection are prescribed with these tablets as they help in stopping the production of new virus in body and clears the infection. Above all, our firm ensure timely shipment of each order of Lamivir HBV Lamivudine Tablets.
Effective Solution for Hepatitis BLamivir HBV Lamivudine Tablets offer a trusted therapeutic option for patients diagnosed with chronic hepatitis B. Their antiviral properties help suppress the virus, supporting doctors and healthcare providers in managing this persistent infection effectively.
Quality Manufacturing and ExportOriginating from India, these tablets adhere to rigorous manufacturing protocols and are distributed worldwide by reputable exporters and suppliers. Each box contains a blister pack of 10 tablets, designed to maintain potency and integrity throughout its two-year shelf life.
Convenient Dosage and StorageWith each tablet containing 100 mg of Lamivudine, dosing is simple and consistent, simplifying adherence for both clinicians and patients. The packaging ensures safe storage for up to two years, preserving quality and effectiveness for extended periods.
FAQs of Lamivir HBV Lamivudine Tablets:
Q: How should Lamivir HBV Lamivudine Tablets be taken for best results?
A: Lamivir HBV Lamivudine Tablets should be taken as directed by a healthcare professional, typically once daily. Its important to take the tablets at the same time each day, with or without food, to maintain stable drug levels in the body.
Q: What is the primary benefit of using Lamivir HBV Lamivudine Tablets?
A: The main benefit of these tablets is their efficacy in suppressing hepatitis B virus replication, slowing the progression of liver disease and reducing the risk of complications associated with chronic infection.
Q: When should this medication be started for hepatitis B treatment?
A: Treatment with Lamivir HBV Lamivudine Tablets typically begins after a confirmed diagnosis of chronic hepatitis B, based on medical evaluation and laboratory findings. Always consult your physician for personalized timing and guidance.
Q: Where are Lamivir HBV Lamivudine Tablets manufactured and supplied from?
A: These tablets are manufactured and exported from India, and are available through authorized exporters, suppliers, and traders who maintain strict quality controls for clinical use.
Q: What is the recommended process for storing these tablets?
A: To ensure maximum potency, store Lamivir HBV Lamivudine Tablets in a cool, dry place, away from direct sunlight, and keep them within their packaging until use. The tablets remain effective for up to two years under proper storage conditions.
Q: How does the packaging format support clinical use?
A: Each box holds 10 tablets in a blister pack, facilitating easy dispensing, dosage tracking, and ensuring sanitary storage for clinical environments.